Shipment of the anti-malarial drug hydroxychloroquine to the US is likely to begin next week, a leading industry in the pharma industry said. Hydroxychloroquine is seen as a game changer in the fight against the COVID-19 pandemic
“Hydroxychloroquine shipments to the US are likely to begin next week. Indian pharma companies are committed to meeting both domestic and export commitments, ”said Sudarshan Jain, general secretary of the Indian Pharmaceutical Alliance.
He said that this is in line with India’s role as the world’s pharmacy.
India supplies 70 percent of the world with hydroxychloroquine.
Jain said that companies like Zydus Cadila and IPCA are the major producers of hydroxychloroquine in the country.
Earlier this week, the Indian pharmaceutical industry said that the country has sufficient reserves of hydroxychloroquine and pharmaceutical companies are ready to increase production to meet domestic and export requirements.
The government said on Friday that the country has sufficient stocks of hydroxychloroquine and is taking all steps to ensure that there is no shortage of medicines in the domestic market.
National Pharmaceutical Pricing Authority (NPPA) chairman Shubhra Singh told PTI, “The country has adequate stock of hydroxychloroquine and we are tracking its demand, availability and production on a daily basis.” ”
Ensuring availability of medicine in the country is the first priority of the government. He said that export is being done here only after the demand is met.